Search Results for “” – Page 3 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Observational Change patient management

403 Publications found

Amoxicillin therapeutic drug monitoring for endocarditis: A comparative study (EI-STAB).

b

International journal of antimicrobial agents

July 1, 2023

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.

b

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

July 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.

b

JCO precision oncology

July 1, 2023

p Cancer

c Change patient management Observational
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma.

b

Journal of cancer research and clinical oncology

July 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease.

b

Therapeutic drug monitoring

June 1, 2023

p Therapeutic drug monitoring

c Change patient management Economics Observational
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement.

b

EClinicalMedicine

June 1, 2023

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.

b

ESMO open

June 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Real-world outcomes among patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in the first-line setting.

b

Cancer medicine

June 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Lessons learned: the first consecutive 1000 patients of the CCCMunich Molecular Tumor Board.

b

Journal of cancer research and clinical oncology

May 1, 2023

p Cancer

c Change patient management Observational
Utilization of Genomic Tumor Profiling in Pediatric Liquid Tumors: A Clinical Series.

b

Hematology reports

April 19, 2023

p Cancer

c Change patient management Clinical outcomes Observational